Bio-Techne (TECH) Shares Outstanding (Diluted Average) (2009 - 2021)
Bio-Techne's quarterly Shares Outstanding (Diluted Average) came in at $41.2 million in Q4 2021, up 2.36% year-on-year from $40.3 million in Q4 2020, and little changed quarter-over-quarter from $41.2 million in Q3 2021.
Bio-Techne has reported Shares Outstanding (Diluted Average) for 12 years, with the latest figure at $41.2 million in Q4 2021.
- For the quarter ending Q4 2021, Shares Outstanding (Diluted Average) rose 2.36% year-over-year to $41.2 million; the trailing twelve-month figure through Dec 2021 stood at $41.2 million (up 2.36% YoY), and the FY2021 full-year result was $40.5 million, up 2.75% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2021 stood at $41.2 million, roughly flat from $41.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $41.2 million in Q4 2021, with the low at $37.5 million in Q1 2017.
- Average Shares Outstanding (Diluted Average) over 5 years is $39.2 million, with a median of $39.1 million recorded in 2019.
- Year-over-year, Shares Outstanding (Diluted Average) increased 0.47% in 2017 and increased 3.15% in 2021.
- Tracing TECH's Shares Outstanding (Diluted Average) over 5 years: stood at $37.9 million in 2017, then rose by 2.17% to $38.7 million in 2018, then advanced by 2.07% to $39.6 million in 2019, then advanced by 1.79% to $40.3 million in 2020, then rose by 2.36% to $41.2 million in 2021.
- The last three Shares Outstanding (Diluted Average) figures came in at $41.2 million (Q4 2021), $41.2 million (Q3 2021), and $40.5 million (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 41.21 Mn |
| Sep 30, 2021 | 41.16 Mn |
| Jun 30, 2021 | 40.48 Mn |
| Mar 31, 2021 | 40.68 Mn |
| Dec 31, 2020 | 40.26 Mn |
| Sep 30, 2020 | 40.03 Mn |
| Jun 30, 2020 | 39.40 Mn |
| Mar 31, 2020 | 39.44 Mn |
| Dec 31, 2019 | 39.55 Mn |
| Sep 30, 2019 | 39.25 Mn |
| Jun 30, 2019 | 38.89 Mn |
| Mar 31, 2019 | 38.86 Mn |
| Dec 31, 2018 | 38.75 Mn |
| Sep 30, 2018 | 38.81 Mn |
| Jun 30, 2018 | 38.06 Mn |
| Mar 31, 2018 | 38.14 Mn |
| Dec 31, 2017 | 37.93 Mn |
| Sep 30, 2017 | 37.71 Mn |
| Jun 30, 2017 | 37.50 Mn |
| Mar 31, 2017 | 37.49 Mn |
| Dec 31, 2016 | 37.48 Mn |
| Sep 30, 2016 | 37.47 Mn |
| Jun 30, 2016 | 37.33 Mn |
| Mar 31, 2016 | 37.30 Mn |
| Dec 31, 2015 | 37.30 Mn |
| Sep 30, 2015 | 37.32 Mn |
| Jun 30, 2015 | 37.23 Mn |
| Mar 31, 2015 | 37.21 Mn |
| Dec 31, 2014 | 37.21 Mn |
| Sep 30, 2014 | 37.15 Mn |
| Jun 30, 2014 | 37.01 Mn |
| Mar 31, 2014 | 37.05 Mn |
| Dec 31, 2013 | 37.02 Mn |
| Jun 30, 2013 | 36.90 Mn |
| Mar 31, 2011 | 37.19 Mn |
| Dec 31, 2010 | 37.16 Mn |
| Sep 30, 2010 | 37.11 Mn |
| Mar 31, 2010 | 37.38 Mn |
| Dec 31, 2009 | 37.35 Mn |
| Sep 30, 2009 | 37.34 Mn |